Parsonex Advisory Services’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
Sell
-611
Closed -$215K 51
2026
Q1
$215K Sell
611
-1,048
-63% -$374K 0.21% 53
2025
Q4
$543K Buy
1,659
+229
+16% +$72.6K 0.35% 54
2025
Q3
$404K Buy
1,430
+11
+0.8% +$3.19K 0.27% 60
2025
Q2
$396K Buy
+1,419
New +$402K 0.33% 61

Other funds holding AMGN

Parsonex Advisory Services's AMGN Position: Q2 2026 in Review

Parsonex Advisory Services sold out of Amgen (AMGN) in Q2 2026, closing a stake of 611 shares — an estimated $215K sold.

Parsonex Advisory Services first reported a position in AMGN in Q2 2025 and held it in 4 quarters. The position peaked at $543K in Q4 2025. 3,133 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Parsonex Advisory Services reported no remaining Amgen position as of Q2 2026 after selling out during the quarter.
  • Parsonex Advisory Services sold 611 Amgen shares in Q2 2026, an estimated $215K.
  • Parsonex Advisory Services first reported a position in Amgen in Q2 2025 and held it in 4 quarters.
  • Parsonex Advisory Services's Amgen position peaked at $543K in Q4 2025.
  • 3,133 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Parsonex Advisory Services's 13F filing for Q2 2026, filed 10 Aug 2026.